Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.73 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.67 |
| ▸ | F3 | P13726 | 3/20 | 0.67 |
| ▸ | USP2 | O75604 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | USP7 | Q93009 | 1/20 | 0.67 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.67 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.67 |
| ▸ | CES2 | O00748 | 1/20 | 0.61 |
| ▸ | CES1 | P23141 | 1/20 | 0.61 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | TOP2A | P11388 | 1/20 | 0.58 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Soyasapogenol A SCHEMBL16431091 | 1.00 | ALOX5 (0.73) | ALOX5PTPN1F3USP2LMNA | |
| Soyasapogenol A SCHEMBL21886589 | 1.00 | ALOX5 (0.73) | ALOX5PTPN1F3USP2LMNA | |
| Soyasapogenol A SCHEMBL5887946 | 1.00 | ALOX5 (0.73) | ALOX5PTPN1F3USP2LMNA | |
| Soyasapogenol A SCHEMBL16431093 | 1.00 | ALOX5 (0.73) | ALOX5PTPN1F3USP2LMNA | |
| Soyasapogenol A SCHEMBL6241027 | 1.00 | ALOX5 (0.73) | ALOX5PTPN1F3USP2LMNA | |
| Soyasapogenol A SCHEMBL5887575 | 1.00 | ALOX5 (0.73) | ALOX5PTPN1F3USP2LMNA | |
| Soyasapogenol A SCHEMBL24626884 | 1.00 | ALOX5 (0.73) | ALOX5PTPN1F3USP2LMNA | |
| SCHEMBL5887703 | 0.89 | ALOX5 (0.67) | ALOX5PTPN1F3USP2LMNA | |
| SCHEMBL5887733 | 0.89 | ALOX5 (0.67) | ALOX5PTPN1F3USP2LMNA | |
| Soyasapogenol B SCHEMBL12509509 | 0.89 | ALOX5 (0.78) | ALOX5PTPN1F3USP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 578 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-12-04 | — | — | US | claimed |
| WO-2024177490-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | 서울대학교산학협력단 | 2024-08-29 | — | — | WO | claimed |
| US-12041907-B2 | Cellulose-synthase-like enzymes and uses thereof | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-07-23 | — | — | US | claimed |
| CN-111993739-B | Transparent polyester film for multilayer coextrusion optics and preparation method thereof | 宁波长阳科技股份有限公司 | 2023-10-03 | — | — | CN | claimed |
| US-20220403437-A1 | GLUCURONOSYLTRANSFERASE, GENE ENCODING SAME AND METHOD FOR USING THE SAME | OSAKA UNIVERSITY (JP) | 2022-12-22 | — | — | US | claimed |
| EP-4052701-A1 | COMPOSITION FOR TGR5 ACTIVATION | Suntory Holdings Limited (JP) | 2022-09-07 | — | — | EP | claimed |
| EP-4046479-A1 | GLUCURONYLTRANSFERASE, GENE ENCODING SAME AND METHOD FOR USING SAME | OSAKA UNIVERSITY (JP) | 2022-08-24 | — | — | EP | claimed |
| CN-114829577-A | Glucuronic acid transferase, gene encoding the same, and method for using the same | 国立大学法人大阪大学 | 2022-07-29 | — | — | CN | claimed |
| US-20220217934-A1 | CELLULOSE-SYNTHASE-LIKE ENZYMES AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-07-14 | — | — | US | claimed |
| CN-114555105-A | TGR5 activating composition | 三得利控股株式会社 | 2022-05-27 | — | — | CN | claimed |
| WO-2004037180-A2 | COMPOSITIONS THAT TREAT OR INHIBIT PATHOLOGICAL CONDITIONS ASSOCIATED WITH INFLAMMATORY RESPONSE | METAPROTEOMICS, LLC (US) | 2004-05-06 | — | — | WO | claimed |
| US-20040086580-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | META PROTEOMICS, LLC | 2004-05-06 | — | — | US | claimed |
| EP-1411959-A1 | CURCUMINOID COMPOSITIONS EXHIBITING SYNERGISTIC INHIBITION OF THE EXPRESSION AND/OR ACTIVITY OF CYCLOOXYGENASE-2 | Metaproteomics, LLC (US) | 2004-04-28 | — | — | EP | claimed |
| US-20030190403-A1 | Soybean processed food | NATIONAL AGRICULTURAL RESEARCH ORGANIZATION (JP) | 2003-10-09 | — | — | US | claimed |
| US-20030108628-A1 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 | FORTRESS CREDIT CORP. (AS COLLATERAL AGENT) | 2003-06-12 | — | — | US | claimed |
| WO-2003007975-A1 | CURCUMINOID COMPOSITIONS EXHIBITING SYNERGISTIC INHIBITION OF THE EXPRESSION AND/OR ACTIVITY OF CYCLOOXYGENASE-2 | METAPROTEOMICS, LLC (US) | 2003-01-30 | — | — | WO | claimed |
| US-20020077350-A1 | Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2 | ASHNI NATURACEUTICALS, INC. | 2002-06-20 | — | — | US | claimed |
| US-20020068098-A1 | Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 | ASHNI NATURACEUTICALS, INC. | 2002-06-06 | — | — | US | claimed |
| WO-2002009698-A1 | COMPOSITIONS EXHIBITING SYNERGISTIC INHIBITION OF THE EXPRESSION AND/OR ACTIVITY OF CYCLOOXYGENASE-2 | ASHNI NATURACEUTICALS, INC. (US) | 2002-02-07 | — | — | WO | claimed |
| US-5770223-A | TOPICAL APPLICATION OF MIXTURES OF PLANT EXTRACTS CONTAINING SAPONINS(OR DERIVATIVES) | LVMH RECHERCHE (FR) | 1998-06-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040086580-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | HPGDS, TPSB2, TPSG1 | ALOX5 296/4885PTPN1 791/4885F3 565/4885 |
| US-20250367305-A1 | ALBUMIN NANOCOMPOSITE COMPRISING PHYTOCHEMICAL AND COMPOSITION FOR IMPROVING MUSCLE DISEASE CONTAINING SAME | ALB, TNNC1, MYOF | ALOX5 3541/4885PTPN1 1058/4885F3 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.